Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07408180

Exploratory Randomized, Controlled, Dose-response Study on the Impact of Nicotine From Five Variants of a Nicotine Tablet (NICOTINE TABLET) on Attention

Impact of Nicotine From Five Variants of a Nicotine Tablet on Attention in Adult Users of Nicotine Pouches: An Exploratory, Randomized, Controlled, Double-blind, Crossover Study

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Philip Morris Products S.A. · Industry
Sex
All
Age
19 Years – 60 Years
Healthy volunteers
Accepted

Summary

This study aims to provide initial insights into the impact of orally delivered nicotine on attentional performance in adult occasional users of nicotine pouches. Nicotine will be administered via a dissolvable tablet for approximately 10 minutes. The main objective of this exploratory study is to characterize the effect of nicotine on attentional performance, using metrics derived from Continuous Performance Test (CPT). Additionally, a second CPT assessment will be conducted two hours after the first administration to explore the potential sustained effects of nicotine on attention as an exploratory objective.

Conditions

Interventions

TypeNameDescription
OTHERNICOTINE TABLET-0mgNICOTINE TABLET (nicotine content 0mg; Mint flavor)
OTHERNICOTINE TABLET-0.5mgNICOTINE TABLET (nicotine content 0.5mg; Mint flavor)
OTHERNICOTINE TABLET-1.0mgNICOTINE TABLET (nicotine content 1.0mg; Mint flavor)
OTHERNICOTINE TABLET-1.5mgNICOTINE TABLET (nicotine content 1.5mg; Mint flavor)
OTHERNICOTINE TABLET-2.0mgNICOTINE TABLET (nicotine content 2.0mg; Mint flavor)

Timeline

Start date
2025-10-28
Primary completion
2026-03-16
Completion
2026-04-23
First posted
2026-02-13
Last updated
2026-02-18

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT07408180. Inclusion in this directory is not an endorsement.